CG Oncology, Inc. (CGON)
NASDAQ · Healthcare
CG Oncology, Inc. Shareholder Equity 2023–2025
CG Oncology, Inc. annual/quarterly shareholder equity history from 2023 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- CG Oncology, Inc. shareholder equity for the quarter ending December 31, 2025 were 752.6M, a 2.62% increase year-over-year.
- CG Oncology, Inc. shareholder equity for 2025 were 752.6M, a 2.62% increase from 2024.
- CG Oncology, Inc. shareholder equity for 2024 were 733.4M, a 695.76% decrease from 2023.
- CG Oncology, Inc. shareholder equity for 2023 were -123.1M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| CG Oncology, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $753 |
| 2024 | $733 |
| 2023 | $-123 |
| CG Oncology, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $753 |
| 2024-12-31 | $733 |
| 2023-12-31 | $-123 |
CG Oncology, Inc. Shareholder Equity — FAQ
CG Oncology, Inc. (CGON) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CGON's shareholder equity history?
The chart and table above show CG Oncology, Inc.'s shareholder equity by year and by quarter, including the growth rate.